Profit Investment Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-9,956
Closed -$705K 89
2017
Q2
$705K Sell
9,956
-1,391
-12% -$92.6K 0.64% 64
2017
Q1
$771K Sell
11,347
-845
-7% -$59.4K 0.63% 67
2016
Q4
$873K Sell
12,192
-131
-1% -$9.74K 0.83% 58
2016
Q3
$975K Sell
12,323
-6,935
-36% -$563K 0.97% 48
2016
Q2
$1.61M Sell
19,258
-30,669
-61% -$2.72M 1.3% 28
2016
Q1
$4.59M Sell
49,927
-22,545
-31% -$2.03M 1.95% 18
2015
Q4
$7.33M Sell
72,472
-79,670
-52% -$8.29M 2.32% 13
2015
Q3
$14.9M Sell
152,142
-23,652
-13% -$2.63M 2.17% 14
2015
Q2
$20.6M Sell
175,794
-246,986
-58% -$27M 2.38% 7
2015
Q1
$41.5M Sell
422,780
-30,625
-7% -$3.11M 2.23% 15
2014
Q4
$42.7M Buy
453,405
+119,760
+36% +$12.4M 2.14% 13
2014
Q3
$35.5M Sell
333,645
-20,350
-6% -$1.99M 1.86% 23
2014
Q2
$29.4M Buy
353,995
+327,605
+1,241% +$25.5M 1.41% 35
2014
Q1
$1.87M Buy
+26,390
New +$2.07M 0.08% 108

Other funds holding GILD

Profit Investment Management's GILD Position: Q3 2017 in Review

Profit Investment Management sold out of Gilead Sciences (GILD) in Q3 2017, closing a stake of 9,956 shares — an estimated $705K sold.

Profit Investment Management first reported a position in GILD in Q1 2014 and held it in 14 quarters. The position peaked at $42.7M in Q4 2014. 1,504 funds tracked by Wall St. Rank hold GILD as of Q3 2017.

  • Profit Investment Management reported no remaining Gilead Sciences position as of Q3 2017 after selling out during the quarter.
  • Profit Investment Management sold 9,956 Gilead Sciences shares in Q3 2017, an estimated $705K.
  • Profit Investment Management first reported a position in Gilead Sciences in Q1 2014 and held it in 14 quarters.
  • Profit Investment Management's Gilead Sciences position peaked at $42.7M in Q4 2014.
  • 1,504 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2017.

Based on Profit Investment Management's 13F filing for Q3 2017, filed 18 Oct 2017.